Back to Atlas
APotentially durableStandard research/education caution
CMP-0054
Discontinued/historical
Furazabol / Miotolan
Ergogenic / AAS
Oral non-aromatizing anabolic steroid history
Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.
Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.
Mechanism & Use
- Compound type
- 17α-alkylated AAS
- Primary mechanism
- DHT-derived AR agonist; A:A ratio not reliably established
- Primary market use
- Anabolic therapy history
Pharmacology
- Molecular weight (Da)
- 330.47
- Oral bioavailability
- Oral; clinically active 17α-alkylated steroid
- Half-life
- ~4-6 h (approx.)
- Route tags
- Oral
- Evidence level
- Historical/clinical
- Clinical status
- Discontinued/historical
- Value-for-money score
- 3 / 10
Reported protocol signal
No popular protocol verified yet; keep as reference compound until protocol signal is added.
For orientation only. See disclaimer — always consult a licensed clinician before use.
Notes
Sparse modern PK/ratio data; included from MESO/WADA lists.